Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

About COVID-19 Vaccines

Two COVID-19 vaccines have received emergency use authorization (EUA) from the U.S. Food and Drug Administration – the Pfizer-BioNTech vaccine and the Moderna vaccine.

Recent studies from Pfizer and Moderna have shown their vaccines to be 95% and 94.5% effective against COVID-19, respectively.

Both vaccines require two doses – an initial shot followed by a booster shot weeks later. UK HealthCare is prepared to provide individuals with both doses, as allocations of each become available, in accordance with Kentucky’s phased distribution plan.

  • Questions about the vaccines

    Q: Is UK HealthCare prepared to provide BOTH vaccine doses required for the Moderna and Pfizer vaccines?

    A: Yes, we are prepared to provide both doses of the vaccine, with the first dose being administered to individuals in accordance with the state’s phased distribution plan. Both vaccines are administered via a shot in the arm in two separate doses on two separate visits. The second booster dose for Pfizer is administered no less than 21 days after the initial dose. The second booster dose for Moderna is administered no less than 28 days after the initial dose.

    Q: If I receive an appointment to get the COVID-19 at the University of Kentucky’s Kroger Field location, how can I know which of the approved vaccines is being administered? What if I’m comfortable with only one of the approved vaccines?

    A: We will communicate which vaccine formulations are being offered. At this time, UK HealthCare is receiving allotments of the Pfizer and Moderna vaccines as they are available.

    Q: What if I am unable to schedule my second Pfizer vaccine dose 21 days later (or 28 days for the Moderna vaccine)?

    A: Guidelines specify that the Pfizer booster dose should not be given earlier than 21 days (or 28 days for the Moderna vaccine), but you will have flexibility on when you schedule the second dose. Our recommendation is that you schedule the second dose as soon as vaccine supplies and your schedule allow. Maximum protection is achieved 7-14 days after the second dose. You will receive an email invitation to schedule your second (booster) does, just as you did with your initial dose.

    Q: Is it possible to contract COVID-19 from the vaccines being produced?

    A: No. None of the vaccines currently in development use the live virus.

  • Safety monitoring

    V-safe is a smartphone-based tool from the CDC that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination. Through v-safe, you can quickly tell the CDC if you have any side effects after getting the COVID-19 vaccine. Depending on your answers, someone from the CDC may call to check on you and get more information. And v-safe will remind you to get your second COVID-19 vaccine dose if you need one.

    The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program run by CDC and the Food and Drug Administration (FDA). Its primary users are healthcare professionals, but any U.S. resident may use it to report an adverse event. VAERS serves as an early warning system to detect possible safety issues with U.S. vaccines by collecting information about adverse events (possible side effects or health problems) that occur after vaccination.